ReviewClinical pharmacology in drug development2021

Assessment of Vedolizumab Disease-Drug-Drug Interaction Potential in Patients With Inflammatory Bowel Diseases.

Wan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.